Carbon ion radiobiology
W Tinganelli, M Durante - Cancers, 2020 - mdpi.com
Simple Summary Radiotherapy with carbon ions has been used for over 20 years in Asia
and Europe and is now planned in the USA. The physics advantages of carbon ions …
and Europe and is now planned in the USA. The physics advantages of carbon ions …
The future of personalised radiotherapy for head and neck cancer
Radiotherapy has long been the mainstay of treatment for patients with head and neck
cancer and has traditionally involved a stage-dependent strategy whereby all patients with …
cancer and has traditionally involved a stage-dependent strategy whereby all patients with …
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 …
D Dearnaley, I Syndikus, H Mossop, V Khoo… - The Lancet …, 2016 - thelancet.com
Background Prostate cancer might have high radiation-fraction sensitivity that would give a
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the …
Y Sun, J Wang, Y Ma, J Li, X Sun, X Zhao, X Shi… - Journal of Experimental …, 2021 - Springer
Background Radioresistance, a poorly understood phenomenon, results in the failure of
radiotherapy and subsequent local recurrence, threatening a large proportion of patients …
radiotherapy and subsequent local recurrence, threatening a large proportion of patients …
Prognostic role of DNA damage response genes mutations and their association with the sensitivity of olaparib in prostate cancer patients
D Zhang, X Xu, Y Wei, X Chen, G Li, Z Lu… - Cancer …, 2022 - journals.sagepub.com
Objective Evidence shows that gene mutation is a significant proportion of genetic factors
associated with prostate cancer. The DNA damage response (DDR) is a signal cascade …
associated with prostate cancer. The DNA damage response (DDR) is a signal cascade …
The implications of genetic testing on radiation therapy decisions: a guide for radiation oncologists
The advent of affordable and rapid next-generation DNA sequencing technology, along with
the US Supreme Court ruling invalidating gene patents, has led to a deluge of germline and …
the US Supreme Court ruling invalidating gene patents, has led to a deluge of germline and …
Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits
T Rafnar, B Gunnarsson, OA Stefansson… - Nature …, 2018 - nature.com
Uterine leiomyomas are common benign tumors of the myometrium. We performed a meta-
analysis of two genome-wide association studies of leiomyoma in European women (16,595 …
analysis of two genome-wide association studies of leiomyoma in European women (16,595 …
[HTML][HTML] Rare germline variants in ATM predispose to prostate cancer: a PRACTICAL Consortium Study
Background Germline ATM mutations are suggested to contribute to predisposition to
prostate cancer (PrCa). Previous studies have had inadequate power to estimate variant …
prostate cancer (PrCa). Previous studies have had inadequate power to estimate variant …
[HTML][HTML] Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and …
While many efforts have been made to pave the way toward human space colonization, little
consideration has been given to the methods of protecting spacefarers against harsh cosmic …
consideration has been given to the methods of protecting spacefarers against harsh cosmic …
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
Peptide receptor radionuclide therapy (PRRT) is a type of radiotherapy that targets peptide
receptors and is typically used for neuroendocrine tumours (NETs). Some of the key …
receptors and is typically used for neuroendocrine tumours (NETs). Some of the key …